CAH
Cardinal Health, Inc.NYSEHealthcare$214.05+0.96%OpenMarket Cap: $50.37B
As of 2026-04-06
Valuation
P/E (TTM)
30.23
PEG
1.12
P/B
-18.71
P/S
0.21
EV/EBITDA
17.52
DCF Value
$340.64
FCF Yield
10.9%
Div Yield
1.0%
Margins & Returns
Gross Margin
3.6%
Operating Margin
1.0%
Net Margin
0.7%
ROE
-58.9%
ROA
3.8%
ROIC
12.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $65.44B | 3.4% | $707.0M | $471.0M | $1.97 | $0.51 |
| Q1 2026 | $64.01B | 3.6% | $668.0M | $450.0M | $1.88 | $0.51 |
| Q4 2025 | $60.16B | 3.7% | $428.0M | $239.0M | $1.00 | $0.51 |
| FY 2025 | $222.58B | 3.7% | $2.27B | $1.56B | $6.45 | $2.02 |
| Q3 2025 | $54.88B | 3.9% | $730.0M | $506.0M | $2.10 | $0.51 |
| Q2 2025 | $55.26B | 3.5% | $549.0M | $400.0M | $1.65 | $0.51 |
| Q1 2025 | $52.28B | 3.6% | $568.0M | $416.0M | $1.70 | $0.51 |
| Q4 2024 | $59.71B | 3.1% | $408.0M | $236.0M | $0.96 | $0.50 |
| FY 2024 | $226.83B | 3.3% | $1.24B | $852.0M | $3.45 | $2.00 |
| Q3 2024 | $54.87B | 3.5% | $369.0M | $261.0M | $1.07 | $1.00 |
| Q2 2024 | $57.44B | 3.2% | $505.0M | $368.0M | $1.50 | $1.00 |
| Q1 2024 | $54.65B | 3.2% | $-32.0M | $-12.0M | $0.02 | $0.50 |